PET/CT全身身体成分与可切除非小细胞肺癌生存的双重机器学习分析
本研究为多中心回顾性研究,纳入769例≤IIIA期可切除非小细胞肺癌(NSCLC)患者,采用双重机器学习评估全身PET/CT身体成分特征与生存的调整关联。结果显示较高的肌间脂肪组织(IMAT)体积指数与更短生存相关,而TAT SUR(Mean)与更长总生存呈探索性有利关联,模型外部队列区分度中等。
要点
- IMAT体积指数每升高1个标准差,总生存减少4.29个月,无进展生存减少2.74个月。
- TAT SUR(Mean)与总生存延长4.42个月呈探索性有利关联。
- 性别分层分析提示男性脂肪体积不良关联更强,女性脂肪代谢有利关联更强。
核心结论
- 全身PET/CT身体成分表型可为可切除NSCLC提供预后信息。
- 较高的IMAT负荷与更短生存相关,TAT SUR(Mean)与总生存呈探索性有利关联。
研究设计与样本
- 回顾性多中心研究,纳入769例≤IIIA期可切除NSCLC患者,术前接受18F-FDG PET/CT。
- 中心1用于模型开发(n=555),中心2用于外部验证(n=214)。
- 采用自动全身分割提取骨骼肌与脂肪组织的体积、衰减及代谢特征。
- 使用基于限制性平均生存时间的双重机器学习与广义倾向评分加权估计调整后差异。
主要发现
- IMAT体积指数每升高1个标准差,总生存的DML调整RMST差异为-4.29个月,无进展生存为-2.74个月。
- TAT SUR(Mean)较高与总生存延长4.42个月呈探索性有利调整关联。
- 性别分层分析提示男性脂肪体积不良关联更强,女性脂肪代谢有利关联更强。
- 模型分析显示外部区分度中等,增量价值指标有限且依赖终点。
临床怎么用
- 全身PET/CT身体成分分析或可辅助可切除NSCLC的研究性风险分层。
- 局部软件框架可能支持可重复的特征提取。
局限性
- 回顾性设计可能引入选择偏倚。
- 外部区分度中等,增量价值有限且依赖终点。
- TAT SUR(Mean)与总生存的关联为探索性,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate whether whole-body PET/CT-derived body composition features are associated with survival in patients with resectable non-small cell lung cancer (NSCLC), using double machine learning to quantify adjusted associations with restricted mean survival time. METHODS: This retrospective multicenter study included 769 patients with stage ≤ IIIA NSCLC who underwent preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and curative resection. Center 1 was used for model development (n = 555) and Center 2 for external validation (n = 214). Automated whole-body segmentation was used to extract volumetric, attenuation-based and metabolic features of skeletal muscle and adipose tissue. Restricted mean survival time-based double machine learning with generalized propensity score weighting estimated DML-adjusted differences in restricted mean survival time for overall survival (OS) and progression-free survival (PFS). Ridge-penalized Cox models were further used to evaluate prognostic performance and incremental value. RESULTS: Higher intermuscular adipose tissue (IMAT) volume index was associated with shorter survival (DML-adjusted RMST difference, -4.29 months for OS and - 2.74 months for PFS per 1-SD higher IMAT volume index). Higher TAT SUR (Mean) showed an exploratory favorable adjusted association with longer OS (+ 4.42 months). Sex-stratified analyses suggested stronger adverse adipose-volume associations in male patients and stronger favorable adipose-metabolic associations in female patients. Model analyses showed moderate external discrimination, whereas incremental-value metrics were modest and endpoint-dependent. CONCLUSION: Whole-body PET/CT body-composition phenotyping may provide prognostic information in resectable NSCLC. Higher IMAT burden was associated with shorter survival, whereas TAT SUR (Mean) showed an exploratory favorable adjusted association with OS. A local software framework may support reproducible feature extraction and research-oriented risk stratification.
引用
- Zhai W, Wang R, Ye M, et al. PET/CT-derived whole-body composition and survival in resectable NSCLC: double machine learning-based adjusted association analysis of intermuscular adiposity burden and sex-specific metabolic phenotypes. Eur J Nucl Med Mol Imaging. 2026. PMID: 42501072. doi:10.1007/s00259-026-08098-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。